会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Oral dosage form for controlled drug release
    • 用于控制药物释放的口服剂型
    • US09144547B2
    • 2015-09-29
    • US12966323
    • 2010-12-13
    • Chi Leung LiLuigi MartiniVincenzo ReHelen Anne Willy
    • Chi Leung LiLuigi MartiniVincenzo ReHelen Anne Willy
    • A61K9/20A61K9/24A61K9/28
    • A61K9/2072
    • An oral dosage form comprising, (i) an erodable core, which core comprises a pharmaceutically active weak base or a pharmaceutically acceptable salt or solvate thereof; and (ii) an erodable coating surrounding said core, which coating comprises one or more openings extending substantially completely through said coating but not penetrating said core and communicating from the environment of use to said core; characterized in that release of the pharmaceutically active weak base or a pharmaceutically acceptable salt or solvate thereof from the dosage form occurs through the said opening(s) by the erosion of said erodable core and through erosion of said erodable coating under pre-determined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine.
    • 口服剂型,其包含(i)可侵蚀的核心,所述核心包含药学活性的弱碱或其药学上可接受的盐或溶剂合物; 和(ii)围绕所述芯的可侵蚀涂层,所述涂层包括基本上完全延伸穿过所述涂层但不穿透所述芯并且从使用环境与所述芯连通的一个或多个开口; 其特征在于药物活性弱碱或其药学上可接受的盐或溶剂合物从剂型的释放通过所述开口通过所述可侵蚀的核心的侵蚀和通过在预定pH条件下侵蚀所述可侵蚀的涂层而发生 ; 制备这种剂型的方法以及在药物中使用这种剂型。